NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / If you're missing teeth, you may be a good candidate for dental implants. These durable devices can restore your ability to chew and speak. In ...
NEW YORK CITY, NY / ACCESS Newswire / February 14, 2025 / If you're missing teeth, you may be a good candidate for dental implants. These durable devices can restore your ability to chew and speak. In ...
The Hong Kong Patent Office granted HK Patent No. HK40097814 to Envoy Medical Corporation on January 3, 2025. The title is Programming of Cochlear Implant Accessories. This patent relates to a system ...
RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...
Shareholder distributions are appropriate. Capital intensity of the industry remains low and gross margins high. In addition, Cochlear enjoys high cash conversion, enabling it to typically pay out 70% ...
Jefferies analyst David Stanton upgraded Cochlear Ltd. shares from Hold to Buy, adjusting the price target slightly upward from AUD305.00 to AUD308.00. The upgrade comes as the $10.91 billion market ...
Tax reform needs to be firmly on the agenda ahead of the looming federal election, Cochlear chief executive Dig Howitt says, ...
Discover Cochlear Limited's Q2 2025 earnings insights: strong implant growth, upcoming product launches, and strategic investments amid Services ...
The Cochlear Ltd (ASX: COH) share price is sinking on Friday after the hearing solutions company's half year result ...
Chicago-based The Aspen Group is seeing their consumer-focused investments pay off, and is ready to double down on those initiatives for continued growth this year. The Aspen Group supports several ...
Here are 10 things to know about the burden of implant costs for ASCs: 1. According to a July 2024 report by Advantien, an ASC supply purchasing company, implants regularly represent one of the ...
Paradromics Inc., a brain implant rival to Elon Musk’s Neuralink Corp., is partnering with Saudi Arabia’s Neom to develop brain-computer interface therapies in the Middle East and North Africa.